Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03580655
Title (PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Blueprint Medicines Corporation
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | NOR | NLD | ITA | GBR | FRA | ESP | DNK | DEU | CAN | AUT

Facility Status City State Zip Country Details
Stanford Cancer Institute Stanford California 94305 United States Details
Rush University Medical Center Chicago Illinois 60612 United States Details
The University of Kansas Cancer Center Westwood Kansas 66205 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Roswell Park Comprehensive Cancer Center Buffalo New York 14263 United States Details
Herbert Irving Comprehensive Cancer Center New York New York 10032 United States Details
University of Pennsylvania, Abramson Cancer Center Philadelphia Pennsylvania 19104 United States Details
University of Texas, MD Anderson Cancer Center Houston Texas 77030 United States Details
Mays Cancer Center San Antonio Texas 78229 United States Details
Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
Medizinische Universität Wien, Universitätsklinik für Innere Medizin I, Klinische Abteilung für Hämatologie und Hämostaseologie Vienna 1090 Austria Details
St. Michael's Hospital Toronto Ontario M5B 1W8 Canada Details
Odense University Hospital, Department of Haematology Odense DK-5000 Denmark Details
Hôpital Necker-Enfants Malades Paris 75015 France Details
CHU Toulouse - Hôpital Larrey Toulouse 31059 France Details
Uniklinik RWTH Aachen, Klinik für Hämatologie, Onkologie, Hämostaseologie und Stammzelltranslplantation Aachen 52074 Germany Details
Universitätsklinikum Hamburg-Eppendorf, Zentrum für Onkologie Hamburg 20246 Germany Details
Universitätsklinikum Leipzig, Medizinische Klinik und Poliklinik I - Hämatologie und Zelltherapie, lnternistische Onkologie, Hämostaseologie Leipzig 04103 Germany Details
Universitätsmedizin Mannheim III. Medizinische Klinik Mannheim 68167 Germany Details
Klinik und Poliklinik für Innere Medizin III, Klinikum rechts der Isar der TU München Munich 81675 Germany Details
Azienda Ospedaliero-Universitaria Careggi, CRIMM - Centro di Ricerca ed Innovazione per le Malattie Mieloproliferative Florence 50134 Italy Details
A.O. OO.RR. S.Giovanni di Dio e Ruggi d'Aragona, University of Salerno Salerno 84131 Italy Details
Centro Ricerche Cliniche di Verona - Azienda Ospedaliera Universitaria Integrata di Verona Verona 37134 Italy Details
University Medical Center Groningen (UMCG) Groningen 9713 GZ Netherlands Details
Oslo University Hospital-Rikshospitalet, Hematology Oslo 0372 Norway Details
Uniwersyteckie Centrum Kliniczne, Klinika Hematologii i Transplantologii Gdańsk 80-214 Poland Details
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wrocławiu, Klinice Hematologii, Nowotworów Krwi i Transplantacji Szpiku Wrocław 50-367 Poland Details
lnstituto de Estudios de Mastocitosis de Castilla la Mancha, Hospital Virgen del Valle - Complejo Hospitalario de Toledo Toledo 45071 Spain Details
Beatson West of Scotland Cancer Centre - NHS Greater Glasgow and Clyde Glasgow G12 0YN United Kingdom Details
Guy's and St Thomas' NHS Foundation Trust - Guy's Hospital London SE1 9RT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field